Salvage pelvic lymph node dissection in recurrent prostate cancer: surgical and early oncological outcome.

ABSTRACT:

Methodology

Seventeen patients with prostate-specific antigen (PSA) rise following local treatment for prostate cancer with curative intent underwent open or minimally invasive salvage pelvic lymph node dissection (SLND) for oligometastatic disease (<4 synchronous metastases) or as staging prior to salvage radiotherapy. Biochemical recurrence after complete biochemical response (cBR) was defined as 2 consecutive PSA increases >0,2 ng/mL; and after incomplete biochemical response as 2 consecutive PSA rises. Newly found metastasis on imaging defined clinical progression (CP). Palliative androgen deprivation therapy (ADT) was initiated if >3 metastases were detected or if patients became symptomatic. Kaplan-Meier statistics were applied.

Results

Clavien-Dindo grade 1, 2, 3a, an

SUBMITTER: Claeys T 

PROVIDER: S-EPMC4324111 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature